Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kari Otterdal

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Thrombosis Research|September 3, 2004
Release of soluble CD40 ligand after platelet activation: studies on the solubilization phaseKari Otterdal, Turid Margrethe Pedersen, Nils Olav Solum
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|March 5, 2011
Cellular sources and inducers of cytokines present in acute wound fluidØystein Grimstad, Øystein Sandanger, Liv Ryan, et al.
Progress in Cardiovascular Diseases|November 26, 2008
Atherosclerotic plaque stability--what determines the fate of a plaque?Bente Halvorsen, Kari Otterdal, Tuva B Dahl, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 2, 2008
Chemokines and cardiovascular riskPål Aukrust, Bente Halvorsen, Arne Yndestad, et al.
Expert Review of Cardiovascular Therapy|September 11, 2010
Activated platelets and atherosclerosisPål Aukrust, Bente Halvorsen, Thor Ueland, et al.
Annals of Medicine|November 3, 2010
Tumor necrosis factor superfamily molecules in acute coronary syndromesPål Aukrust, Wiggo J Sandberg, Kari Otterdal, et al.
The Journal of Nutrition|October 22, 2008
The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjectsKirsten B Holven, Pål Aukrust, Kjetil Retterstøl, et al.
The Journal of Clinical Endocrinology and Metabolism|December 3, 2014
Increased serum and bone matrix levels of the secreted Wnt antagonist DKK-1 in patients with growth hormone deficiency in response to growth hormone treatmentThor Ueland, Nicoleta Cristina Olarescu, Anders P Jørgensen, et al.
European Heart Journal|February 18, 2005
Soluble CD40 ligand in acute and chronic heart failureThor Ueland, Pål Aukrust, Arne Yndestad, et al.
Frontiers in Immunology|January 6, 2022
Lasting Immunological Imprint of Primary Epstein-Barr Virus Infection With Associations to Chronic Low-Grade Inflammation and FatigueBørre Fevang, Vegard Bruun Bratholm Wyller, Tom Eirik Mollnes, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Thrombosis Research|September 3, 2004
Release of soluble CD40 ligand after platelet activation: studies on the solubilization phaseKari Otterdal, Turid Margrethe Pedersen, Nils Olav Solum
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|March 5, 2011
Cellular sources and inducers of cytokines present in acute wound fluidØystein Grimstad, Øystein Sandanger, Liv Ryan, et al.
Progress in Cardiovascular Diseases|November 26, 2008
Atherosclerotic plaque stability--what determines the fate of a plaque?Bente Halvorsen, Kari Otterdal, Tuva B Dahl, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 2, 2008
Chemokines and cardiovascular riskPål Aukrust, Bente Halvorsen, Arne Yndestad, et al.
Expert Review of Cardiovascular Therapy|September 11, 2010
Activated platelets and atherosclerosisPål Aukrust, Bente Halvorsen, Thor Ueland, et al.
Annals of Medicine|November 3, 2010
Tumor necrosis factor superfamily molecules in acute coronary syndromesPål Aukrust, Wiggo J Sandberg, Kari Otterdal, et al.
The Journal of Nutrition|October 22, 2008
The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjectsKirsten B Holven, Pål Aukrust, Kjetil Retterstøl, et al.
The Journal of Clinical Endocrinology and Metabolism|December 3, 2014
Increased serum and bone matrix levels of the secreted Wnt antagonist DKK-1 in patients with growth hormone deficiency in response to growth hormone treatmentThor Ueland, Nicoleta Cristina Olarescu, Anders P Jørgensen, et al.
European Heart Journal|February 18, 2005
Soluble CD40 ligand in acute and chronic heart failureThor Ueland, Pål Aukrust, Arne Yndestad, et al.
Frontiers in Immunology|January 6, 2022
Lasting Immunological Imprint of Primary Epstein-Barr Virus Infection With Associations to Chronic Low-Grade Inflammation and FatigueBørre Fevang, Vegard Bruun Bratholm Wyller, Tom Eirik Mollnes, et al.
Pageof 6